In the matched cohort of people with T2DM and compensated liver cirrhosis, 627 (30.63%) insulin users and 979 (23.91%) insulin nonusers died during the follow-up period (incidence rate of 5.28 vs 4.07 per 100 patient-years, respectively). The gene discussed is INS; the disease is type 2 diabetes mellitus.